Astria Non Currrent Assets Other vs Total Assets Analysis
ATXS Stock | USD 8.85 0.02 0.23% |
Astria Therapeutics financial indicator trend analysis is way more than just evaluating Astria Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Astria Therapeutics is a good investment. Please check the relationship between Astria Therapeutics Non Currrent Assets Other and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astria Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Astria Stock please use our How to Invest in Astria Therapeutics guide.
Non Currrent Assets Other vs Total Assets
Non Currrent Assets Other vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Astria Therapeutics Non Currrent Assets Other account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Astria Therapeutics' Non Currrent Assets Other and Total Assets is 0.94. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Total Assets in the same time period over historical financial statements of Astria Therapeutics, assuming nothing else is changed. The correlation between historical values of Astria Therapeutics' Non Currrent Assets Other and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Astria Therapeutics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Currrent Assets Other i.e., Astria Therapeutics' Non Currrent Assets Other and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Total Assets
Total assets refers to the total amount of Astria Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Astria Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Astria Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Astria Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astria Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Astria Stock please use our How to Invest in Astria Therapeutics guide.Selling General Administrative is likely to drop to about 12.7 M in 2024. Issuance Of Capital Stock is likely to drop to about 82.6 M in 2024
Astria Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Astria Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Astria Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 41.8M | 47.5M | 127.5M | 230.6M | 254.7M | 267.4M | |
Other Current Liab | 2.6M | 4.2M | 3.3M | (788K) | 9.7M | 10.2M | |
Total Current Liabilities | 5.0M | 6.4M | 5.2M | 582K | 11.6M | 6.2M | |
Total Stockholder Equity | 35.7M | 40.7M | 122.3M | 221.2M | 243.1M | 255.3M | |
Property Plant And Equipment Net | 2.3M | 966K | 394K | 948K | 363K | 706.5K | |
Net Debt | (7.6M) | (23.9M) | (86.1M) | (19.6M) | (175.4M) | (166.6M) | |
Retained Earnings | (223.6M) | (260.9M) | (455.8M) | (507.6M) | (580.5M) | (551.5M) | |
Accounts Payable | 1.2M | 1.5M | 1.6M | 788K | 1.5M | 1.3M | |
Cash | 9.9M | 24.9M | 86.5M | 20.5M | 175.7M | 184.5M | |
Non Current Assets Total | 2.8M | 1.1M | 439K | 4.2M | 3.7M | 3.9M | |
Non Currrent Assets Other | 473K | 165K | 45K | 3.2M | 3.4M | 3.5M | |
Cash And Short Term Investments | 36.2M | 44.9M | 125.5M | 226.4M | 246.7M | 259.0M | |
Common Stock Shares Outstanding | 1.9M | 3.1M | 8.9M | 14.6M | 30.1M | 31.6M | |
Liabilities And Stockholders Equity | 41.8M | 47.5M | 127.5M | 230.6M | 254.7M | 267.4M | |
Non Current Liabilities Total | 56K | 1.0M | 397K | 1.9M | 8.8M | 0.0 | |
Other Current Assets | 2.7M | 1.4M | 1.6M | 1.3M | 4.2M | 4.5M | |
Other Stockholder Equity | 259.3M | 301.5M | 481.7M | 632.5M | 823.6M | 864.8M | |
Total Liab | 6.1M | 6.8M | 5.2M | 9.4M | 11.6M | 17.9M | |
Total Current Assets | 39.0M | 46.3M | 127.1M | 226.4M | 250.9M | 263.5M | |
Common Stock | 12K | 20K | 13K | 28K | 41K | 43.1K | |
Short Term Investments | 26.3M | 20M | 39M | 205.9M | 71M | 54.9M | |
Net Tangible Assets | 35.7M | 40.7M | 25.9M | 124.8M | 143.5M | 150.7M | |
Other Assets | 473K | 165K | 45K | 3.2M | 1.0 | 0.95 | |
Common Stock Total Equity | 7K | 12K | 20K | 28K | 32.2K | 20.0K | |
Net Invested Capital | 35.7M | 40.7M | 25.9M | 124.8M | 147.8M | 155.2M | |
Property Plant And Equipment Gross | 2.3M | 966K | 394K | 948K | 363K | 616.8K | |
Net Working Capital | 33.9M | 39.9M | 121.9M | 218.6M | 239.4M | 251.4M | |
Capital Stock | 12K | 20K | 96.4M | 96.4M | 95.4M | 52.8M |
Pair Trading with Astria Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Astria Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astria Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Astria Stock
0.92 | MESO | Mesoblast Fiscal Year End 4th of September 2024 | PairCorr |
0.66 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
0.61 | JPHLF | Japan Post Holdings | PairCorr |
0.58 | JPSTF | JAPAN POST BANK | PairCorr |
The ability to find closely correlated positions to Astria Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Astria Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Astria Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Astria Therapeutics to buy it.
The correlation of Astria Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Astria Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Astria Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Astria Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Astria Stock Analysis
When running Astria Therapeutics' price analysis, check to measure Astria Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astria Therapeutics is operating at the current time. Most of Astria Therapeutics' value examination focuses on studying past and present price action to predict the probability of Astria Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astria Therapeutics' price. Additionally, you may evaluate how the addition of Astria Therapeutics to your portfolios can decrease your overall portfolio volatility.